CFOR — CapForce Share News
0.000.00%
Last trade - 00:00- $24.36m
- $23.83m
- $30.20m
Brief: Opgen Inc - Received Nasdaq Notice That Co Is Not In Compliance With Minimum Stockholders' Equity Requirement For Continued Listing
Brief: OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
Brief: OpGen Announces 1-For-10 Reverse Stock Split
Brief: David E. Lazar Reports 19.9% Stake In Opgen Inc As Of March 25- SEC Filing
Brief: Opgen Announces Acquisition Of Preferred Stock By David Lazar
OpGen jumps after private investor to take over as CEO
10x Genomics sues rival Curio over gene-sequencing technology
Brief: OpGen Q3 basic EPS USD -0.46
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
U.S. STOCKS ON THE MOVE-First Solar, Genetron, Viasat
U.S. STOCKS ON THE MOVE-Albemarle, Delta, OpGen
OpGen rises after sale of certain diagnostic platform tests
Brief: OpGen- On Oct 6, Unit Curetis GmbH Received Payment Of 750,000 Euros Related To Sale Of Certain Unyvero A50 Systems By Curetis To Strategic Partner
Brief: Opgen CEO, CFO & COO Agreed To Amend Employment Agreements To Cut Annual Base Salaries
OpGen Inc reports results for the quarter ended in June - Earnings Summary
Brief: OpGen, Inc. Q2 revenue USD 700 thousand
OpGen Inc expected to post a loss of 71 cents a share - Earnings Preview
Brief: OpGen Subsidiary Curetis And Find Extend Research And Development Collaboration Agreement